HomeCompareCYBNY vs MRK

CYBNY vs MRK: Dividend Comparison 2026

CYBNY yields 2857.14% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CYBNY wins by $285724556560.03M in total portfolio value
10 years
CYBNY
CYBNY
● Live price
2857.14%
Share price
$0.07
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$285724556560.08M
Annual income
$267,319,527,558,731,650.00
Full CYBNY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CYBNY vs MRK

📍 CYBNY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCYBNYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CYBNY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CYBNY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CYBNY
Annual income on $10K today (after 15% tax)
$242,857.14/yr
After 10yr DRIP, annual income (after tax)
$227,221,598,424,921,900.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CYBNY beats the other by $227,221,598,424,913,570.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CYBNY + MRK for your $10,000?

CYBNY: 50%MRK: 50%
100% MRK50/50100% CYBNY
Portfolio after 10yr
$142862278280.07M
Annual income
$133,659,763,779,370,720.00/yr
Blended yield
93.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CYBNY
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CYBNY buys
0
MRK buys
0
No recent congressional trades found for CYBNY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCYBNYMRK
Forward yield2857.14%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$285724556560.08M$56.8K
Annual income after 10y$267,319,527,558,731,650.00$9,798.13
Total dividends collected$284448663636.43M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CYBNY vs MRK ($10,000, DRIP)

YearCYBNY PortfolioCYBNY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$296,414$285,714.29$11,206$366.19+$285.2KCYBNY
2$8,232,097$7,914,934.20$12,650$502.35+$8.22MCYBNY
3$214,243,566$205,435,221.63$14,407$694.19+$214.23MCYBNY
4$5,225,999,702$4,996,759,086.15$16,585$967.82+$5225.98MCYBNY
5$119,502,966,841$113,911,147,159.88$19,342$1,363.89+$119502.95MCYBNY
6$2,562,267,139,226$2,434,398,964,706.24$22,913$1,947.19+$2562267.12MCYBNY
7$51,522,962,512,220$48,781,336,673,248.19$27,662$2,823.89+$51522962.48MCYBNY
8$971,869,901,477,056$916,740,331,588,980.50$34,159$4,173.35+$971869901.44MCYBNY
9$17,200,961,683,505,388$16,161,060,888,924,940.00$43,337$6,308.80+$17200961683.46MCYBNY
10$285,724,556,560,082,430$267,319,527,558,731,650.00$56,776$9,798.13+$285724556560.03MCYBNY

CYBNY vs MRK: Complete Analysis 2026

CYBNYStock

Cyber Security 1 AB (publ), a cyber security company, provides cyber services and software solutions in Africa, the Middle East, Europe, and the United Arab Emirates. It operates through three segments: Distribution; Advisory Services; and MSSP/ Managed Services. The company also offers security, risk, and compliance solutions for payment, communication, network, and e-commerce security. In addition, it provides system security, GRC solutions, incident response, and forensics initial license and periodic maintenance agreements covering product updates and customer support; and professional advisory services, which includes legal compliance, installation, and integration of various cyber security system components. Further, the company offers MSSP/Managed services, such as data, network, and gateway securities; and managed compliance and SIEM services, incident response, and business continuity and cyber forensics. It serves public and private sector organizations, including financial, government, healthcare, retail, insurance, manufacturing, and hospitality. The company was formerly known as Cognosec AB (publ) and changed its name to Cyber Security 1 AB (publ) in July 2018. Cyber Security 1 AB (publ) was incorporated in 1970 and is headquartered in Stockholm, Sweden.

Full CYBNY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CYBNY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CYBNY vs SCHDCYBNY vs JEPICYBNY vs OCYBNY vs KOCYBNY vs MAINCYBNY vs JNJCYBNY vs ABBVCYBNY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.